Sanjay Nayak News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sanjay nayak. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sanjay Nayak Today - Breaking & Trending Today

Sanjay Nayak Sells 2,274 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) Stock

Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) insider Sanjay Nayak sold 2,274 shares of Ocular Therapeutix stock in a transaction on Thursday, May 23rd. The shares were sold at an average price of $5.84, for a total value of $13,280.16. Following the sale, the insider now directly owns 178,026 shares of the company’s stock, […] ....

New York , United States , Sanjay Nayak , Piper Sandler , Raymond James Associates , Ocular Therapeutix Inc , Rafferty Asset Management , York State Common Retirement Fund , Raymond James Financial Services Advisors Inc , Barclays Plc , Securities Exchange Commission , Ocular Therapeutix , Get Free Report , Exchange Commission , James Financial Services Advisors , Ocular Therapeutix Daily ,

Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024

Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Madhoosudan Patil , Sanjay Nayak , Chintan Patel , Pravinu Dugel , Research Development , Nonclinical Development , Exchange Commission , Panel Title , Association For Research , Ocular Therapeutix Inc , Aboutoculartherapeutix Inc , Seattle Convention Center , Company Phase , Two Ophthalmology Meetings , Ophthalmology Innovation Source , Chief Strategy , Executive Chairman , Chief Executive , Convention Center , Chuck Blizzard , Vice President , Exhibit Hall , Seattle Convention , Associate Director , Ocular Therapeutix ,

Curtains for Rs 3,300-crore SPECS scheme; new PLI after polls

Curtains for Rs 3,300-crore SPECS scheme; new PLI after polls
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Sanjay Nayak , Ashwini Vaishnaw , Ajai Chowdhry , Sunil Vachani , Tejas Networks , Dixon Technologies ,

Ocular Therapeutix Reports Fourth Quarter and Full Year 2023 Results

11.03.2024 - Leadership Appointments Move Ocular Towards Being a Leader in Retinal Care Screening Underway in AXPAXLI Phase 3 SOL-1 Trial for Wet AMD Topline Clinical Data for AXPAXLI in Diabetic Retinopathy and PAXTRAVA in Glaucoma Expected in Q2 2024 Cash . ....

Jeff Heier , Joyce Allaire , Donald Notman , Sanjay Nayak , Pravin Dugel , Peter Kaiser , Ocular Therapeutix Inc , Exchange Commission , Cash Expected , Support Operations Into At Least , Balance Plus , Gross Proceeds , Investor Day , Outline Updated Corporate , Executive Chairman , Chief Scientific Officer , Medical Director , Chief Strategy Officer , Special Protocol Assessment Agreement , Upcoming Milestones , Ocular Therapeutix Investor Day , Topline Phase , Year End , Ocular Therapeutix , Safety Information , Private Securities Litigation Reform Act ,

Ocular Therapeutix™ Reports Fourth Quarter And Full Year 2023 Results

Ocular Therapeutix™ Reports Fourth Quarter And Full Year 2023 Results
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Jeff Heier , Pravin Dugel , Peter Kaiser , Joyce Allaire , Donald Notman , Sanjay Nayak , Exchange Commission , Ocular Therapeutix Inc , Leadership Appointments Move Ocular Towards Being , Clinical Data , Diabetic Retinopathy , Glaucoma Expected , Support Operations Into At Least , Balance Plus , Gross Proceeds , Investor Day , Outline Updated Corporate Strategy , Executive Chairman , Ocular Therapeutix , Chief Scientific Officer , Medical Director , Chief Strategy Officer , Special Protocol Assessment Agreement , Upcoming Milestones , Ocular Therapeutix Investor Day , Topline Phase ,